In Vitro Discovery of a Therapeutic Lead for HFMD From a Library Screen of Rocaglates/Aglains
Journal of Medical Virology · 2025-02 · 97 (2)
DOI: 10.1002/jmv.70228 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 08.02.2025. Verfasst von Adrian Oo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National U…. Hauptthemen laut MEDLINE: Antiviral Agents, Enterovirus A, Human, Hand, Foot and Mouth Disease, Benzofurans. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCATS NIH HHS, NIH HHS, This work was supported by Singapore National Research Foundation Competitive Research Programme (NRF-CRP21-2018-0004) (SA & JJHC), Singapore Ministry of Educa….
Abstract (Originalsprache)
The lack of effective antiviral treatments for enteroviruses, including human enterovirus A71 (EV‐A71), have resulted in an immense global healthcare burden associated with hand‐foot‐and‐mouth disease (HFMD). Rocaglates and aglains belong to a family of compounds produced by Aglaia genus plants. Since the initial discovery of rocaglates in 1982, various rocaglates and aglains have been synthesized and extensively studied mainly as anticancer agents. Here, we report the discovery of a novel aglain derivative as a potential EV‐A71 inhibitor. From an immunofluorescence‐based phenotypic screen of a library of 296 rocaglate and aglain derivatives, we identified a lead aglain which effectively suppressed EV‐A71 replication by 2.3 log fold at a non‐cytotoxic concentration, with a host cell CC 50 of 21.78 µM, an EV‐A71 infection EC 50 of 3.57 µM, and a selectivity index of 6.1. Further validation revealed inhibition of EV‐A71 across multiple human cell types and a pan‐enterovirus inhibitory spectrum against other enteroviruses. Subsequent mechanistic investigation revealed interference with EV‐A71 intracellular post‐entry events including viral RNA transcription and translation. Findings from this study have established a strong foundation for development of aglain scaffolds as much needed antiviral agents for HFMD, paving the way for future medicinal chemistry optimization and in vivo studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular RNA Virology and Antiviral Strategies, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Infectious Diseases Translational Research Programme, Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Department of Chemistry and Center for Molecular Discovery (BU-CMD), Boston University, Boston, Massachusetts, USA.
- Immunology Programme, Life Sciences Institute, National University of Singapore, Singapore, Singapore.
- Institute of Molecular and Cell Biology, Agency for Science, Technology and Research (A*STAR), Singapore, Singapore.
- NUSMed Biosafety Level 3 Core Facility, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
ORCID-Profile: Angel Borge, Michael Ricca, Lauren E Brown, John A Porco, Justin Jang Hann Chu
Förderung
- NCATS NIH HHS
- NIH HHS
- This work was supported by Singapore National Research Foundation Competitive Research Programme (NRF-CRP21-2018-0004) (SA & JJHC), Singapore Ministry of Educa…
- NIAID NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Oo, A., Borge, A., Lee, R. C. H., Salim, C. K., Wang, W., Ricca, M., Fong, D. Y., Alonso, S., Brown, L. E., Porco, J. A., & Chu, J. J. H. (2025). In Vitro Discovery of a Therapeutic Lead for HFMD From a Library Screen of Rocaglates/Aglains. Journal of Medical Virology, 97(2). https://doi.org/10.1002/jmv.70228
Vancouver
Oo A, Borge A, Lee RCH, Salim CK, Wang W, Ricca M, et al. In Vitro Discovery of a Therapeutic Lead for HFMD From a Library Screen of Rocaglates/Aglains. Journal of Medical Virology. 2025;97(2). doi:10.1002/jmv.70228
BibTeX
@article{Oo2025,
author = {Oo, Adrian and Borge, Angel and Lee, Regina Ching Hua and Salim, Cyrill Kafi and Wang, Wenyu and Ricca, Michael and Fong, Deborah Yuhui and Alonso, Sylvie and Brown, Lauren E and Porco, John A and Chu, Justin Jang Hann},
title = {In Vitro Discovery of a Therapeutic Lead for HFMD From a Library Screen of Rocaglates/Aglains},
journal = {Journal of Medical Virology},
year = {2025},
volume = {97},
number = {2},
doi = {10.1002/jmv.70228}
}
EUVIMED